市場調查報告書
商品編碼
1084876

細胞毒藥物合同製造市場規模/份額/前景/機會(2022-2028):生產規模/形式/產品類型/地區

Cytotoxic Drugs Contract Manufacturing Market, by Production Scale, by Form, by Product Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

細胞毒性藥物的合同製造市場在過去十年中顯著增長。癌症發病率增加、大公司業務擴張以及聯盟和收購等各種增長戰略的增加等因素預計將在預測期內推動市場增長。製藥公司越來越多地採用合同製造服務也有望在預測期內推動市場增長。

本報告調查了全球細胞毒藥物合同製造市場,定義和概述了市場,分析了對市場增長、法律和監管環境、技術趨勢、市場規模變化和預測的各種影響因素,總結了細分市場各品類/地區/主要國家、競爭環境、主要公司概況等。

目錄

第 1 章調查目標/先決條件

第二章市場概述

第三章市場動態/法律法規/趨勢分析

  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會
  • 影響分析
  • 流行病學
  • 市場趨勢
  • 產品發布
  • 監管場景
  • PEST 分析
  • 併購場景
  • 技術進步

第 4 章全球細胞毒性藥物合同製造市場:按生產規模

  • 產業規模
  • 中試規模
  • 實驗室規模

第 5 章全球細胞毒性藥物合同製造市場:按形式

  • 液體
  • 純色

第 6 章全球細胞毒性藥物合同製造市場:按產品類型

  • 口服製劑
  • 靜脈注射

第 7 章全球細胞毒性藥物合同製造市場:按地區

  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章競爭態勢

  • 熱圖分析
  • 市場份額分析
    • Lonza Group
    • Piramal Group
    • Evonik Industries AG
    • Novasep Holding SAS
    • Merck KGaA(SAFC Pharma)
    • Baxter Biopharma Solutions
    • AbbVie Contract Manufacturing
    • Cambrex Corporation
    • CordenPharma International
    • BSP Pharmaceuticals SpA
    • Catalent, Inc.
    • Albany Molecular Research Inc.(AMRI)
    • Evotec
    • WuXi AppTec Co., Ltd.
    • Pierre Fabre Laboratories
    • Dishman Group
  • 分析師見解

第9章 章節

目錄
Product Code: CMI3175

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2021, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2021, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study:

  • This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Detailed Segmentation:

  • Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale:
    • Industrial scale
    • Pilot Scale
    • Laboratory Scale
  • Global Cytotoxic Drugs Contract Manufacturing Market, By Form:
    • Liquid
    • Solid
  • Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type:
    • Oral
    • Intravenous
  • Global Cytotoxic Drugs Contract Manufacturing Market, By Region:
    • North America
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Production Scale:
      • Industrial scale
      • Pilot Scale
      • Laboratory Scale
      • By Form:
      • Liquid
      • Solid
      • By Product Type:
      • Oral
      • Intravenous
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Lonza Group*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Piramal Group
    • Evonik Industries AG
    • Novasep Holding SAS
    • Merck KGaA (SAFC Pharma)
    • Baxter Biopharma Solutions
    • AbbVie Contract Manufacturing
    • Cambrex Corporation
    • BSP Pharmaceuticals S.p.A.
    • CordenPharma International
    • Catalent, Inc.
    • Albany Molecular Research Inc. (AMRI)
    • Evotec
    • WuXi AppTec Co., Ltd.
    • Pierre Fabre Laboratories
    • Dishman Group

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Production Scale
    • Market Snippet, By Form
    • Market Snippet, By Product Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Epidemiology
  • Market Trends
  • Product Launch
  • Regulatory Scenario
  • PEST Analysis
  • Merger and Acquisition Scenario
  • Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028(%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Industrial scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Pilot Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Laboratory Scale
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028(%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Solid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028(%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Production Scale, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Form, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Lonza Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Piramal Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Evonik Industries AG
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novasep Holding SAS
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA (SAFC Pharma)
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Baxter Biopharma Solutions
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Contract Manufacturing
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cambrex Corporation
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CordenPharma International
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BSP Pharmaceuticals S.p.A.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Catalent, Inc.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Albany Molecular Research Inc. (AMRI)
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Evotec
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • WuXi AppTec Co., Ltd.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pierre Fabre Laboratories
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dishman Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact